Drug interactions amongst companion animal parasiticides
Ian Wright
Wednesday, May 2, 2018
The global burden of ectoparasitic infestations is exacerbated by the lack of licensed vaccines, making safe and effective parasiticide drugs vital to their prevention and treatment. The last two decades in the companion animal parasiticides market has brought a welcome surge in the number of new antiparasitic agents. However, this requires veterinary prescribers to be much more knowledgeable about drug mode of action, indications, adverse reactions, and the potential for drug-drug interactions. Most antiparasitic drugs have an acceptable safety margin, however some are associated with clinically significant side effects or drug-drug interactions. The risk for these side effects can be increased when drugs are used in combination and by concurrent medications prescribed for preexisting conditions. This article describes the risk of acute adverse reactions associated with treatment with antiparasitic drugs and highlights the current safety warnings regarding concurrent use of some drugs.
Subscribe to get full access to The Veterinary Nurse
Thank you for vising The Veterinary nurse and reading our archive of expert clinical content. If you would like to read more from the leading peer-reviewed journal for veterinary nurses, you can start your subscription today for just £26.
Subscribing will enable you to:
- Stay up-to-date with current thinking and best practice in veterinary medicine
- Enhance your knowledge and understanding of all key clinical topics
- Achieve the mandatory requirement of 45 hours' documented CPD over a three-year period